1-decene is an alkene that is decane containing one double bond at position 1.
定義
1-decene is an alkene that is decane containing one double bond at position 1. It has a role as a metabolite.
出典: PubChem
米国FDA 物質登録 · UNII 7O4U4C718P · 登録名 1-Decene · 単一の化学物質
化粧品での役割
粘度を調整するVISCOSITY CONTROLLING他の成分を溶かす基剤SOLVENT
安全性・規制情報
韓国の有害物質GHS分類なし · 既存化学物質
Other restriction: ban substances that deplete the ozone layer
出典: EU CosIng 成分リスト
詳しい資料 — 表示名・識別番号・物性・試験記録・文献
別名・識別情報
DECENEINCI데센韓国の表示名（食薬処標準名）1-Decene別名
- CAS No.化学物質登録番号
- 872-05-9
- EC No.EU化学物質目録番号
- 212-819-2
- DTXSID米国EPA化学物質番号
- DTXSID8027329
- DTXCID米国EPA化合物番号
- DTXCID507329
- IUPAC
- Dec-1-ene
- 分子式
- C10H20
- 分子量
- 140.27 g/mol
測定された物性
- 性状
- 液体
- 臭いの閾値
- 7 ppm
- 融点・凝固点
- -66.3 ℃
- 初留点および沸点範囲
- 170.5 ℃
- 引火点
- &, lt, 55 ℃
- 燃焼・爆発範囲の上限/下限
- 5.4 / 0.5 %
- 蒸気圧
- 1.67 ㎜Hg
- 溶解度
- 0.00057 g/100㎖
- 蒸気密度
- 4.84
- 比重
- 0.7408
- n-オクタノール/水分配係数（Kow）
- 5.7
- 自然発火温度
- 235 ℃
- 粘度
- 0.75 cP (at 20 ℃)
- 分子量
- 140.266
物質そのものを測定した値です。安全保健公団（KOSHA）の資料はSDS作成・確認の参考用で、原料商品の規格ではありません。
出典: 韓国安全保健公団 SDS
製品が実際に使っている用途
米国EPAにこの成分を届け出た製品13件の用途です。化粧品以外の製品も含まれるため、上の数行がこの成分の主な使い道といえます。
- Intermediate3
- Viscosity modifier2
- Lubricating agent2
- Fuel2
- Solvent2
- Monomers2
出典: 米国EPA CompTox
刺激・感作試験の記録
皮膚試験19件・眼試験7件の記録があります。
刺激が強いと分類5件中程度と分類3件低いと分類31件
試験ごとに結論が分かれています（最も多い結論の割合 13%）。この成分が刺激性だとは言い切れないということです。 原料そのものを試験した記録で、完成品に含まれる濃度での刺激性とは異なります。
試験26件をすべて見る
- Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: Magnusson and Kligman - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: U.S. EPA FIFRA (Pesticide Assessment Guidelines Subdivision F/TSCA (798.4470) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to - Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act (FHSLA) according to - Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substance Labelling Act (FHSLA) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) OPPTS 870.2500 according to - Category 6.3A (Category 2)
Skin Irritation · Read Across - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.41 according to - Category 2
Skin Irritation · Screening - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to - Not classified
Eye Irritation · Screening - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
出典: 米国EPA CompTox